Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

PURPOSE: Simponi(®) (golimumab, MSD) is a fully human monoclonal antibody against tumor necrosis factor alpha administered subcutaneously using an autoinjector or a prefilled syringe. This study examined preference for administration of golimumab by autoinjector or prefilled syringe in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeire, Séverine, D’heygere, François, Nakad, Antoine, Franchimont, Denis, Fontaine, Fernand, Louis, Edouard, Van Hootegem, Philippe, Dewit, Olivier, Lambrecht, Guy, Strubbe, Beatrijs, Baert, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039065/
https://www.ncbi.nlm.nih.gov/pubmed/30013330
http://dx.doi.org/10.2147/PPA.S154181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039065/
https://www.ncbi.nlm.nih.gov/pubmed/30013330
http://dx.doi.org/10.2147/PPA.S154181

Ejemplares similares